Benigno C Valdez Selected Research

Benigno C Valdez Research Topics

Disease

11	Neoplasms (Cancer) 01/2023 - 10/2012
11	Lymphoma (Lymphomas) 10/2022 - 05/2012
10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 11/2008
7	Myeloid Leukemia (Leukemia, Myelocytic) 11/2018 - 11/2008
6	Leukemia 03/2024 - 06/2011
3	Hematologic Neoplasms (Hematological Malignancy) 10/2022 - 07/2010
3	Mandibulofacial Dysostosis (Treacher Collins Syndrome) 10/2005 - 07/2004
2	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2024 - 06/2011
2	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 01/2018
2	Multiple Myeloma 01/2020 - 08/2013
2	Mucositis 06/2017 - 01/2016
2	Dermatitis 06/2017 - 01/2016
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2016 - 06/2011
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2016 - 06/2011
1	Chronic Pain 03/2024
1	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2020
1	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2012

Drug/Important Bio-Agent (IBA)

19	Busulfan (Busulfex)FDA Link 10/2022 - 11/2008
11	Gemcitabine FDA Link 10/2022 - 05/2012
10	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 07/2010
8	Alkylating AgentsIBA 01/2023 - 05/2012
8	NucleosidesIBA 01/2023 - 05/2012
8	Melphalan (Alkeran)FDA LinkGeneric 10/2022 - 10/2012
8	Clofarabine (Clolar)FDA Link 01/2022 - 06/2011
7	fludarabineIBA 01/2022 - 06/2011
5	Vorinostat FDA Link 01/2022 - 05/2012
4	Proteins (Proteins, Gene)FDA Link 10/2022 - 09/2016
4	PanobinostatIBA 01/2022 - 11/2016
4	Decitabine FDA Link 01/2022 - 03/2010
3	Drug CombinationsIBA 03/2024 - 11/2015
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2022 - 11/2017
3	Histone Deacetylase InhibitorsIBA 10/2022 - 07/2014
3	venetoclaxIBA 01/2022 - 01/2020
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024 - 11/2018
2	ChromatinIBA 10/2022 - 01/2018
2	olaparibIBA 01/2022 - 11/2017
2	perfosfamideIBA 11/2018 - 01/2017
2	romidepsin (FK228)FDA Link 01/2018 - 09/2016
2	Rituximab (Mabthera)FDA Link 01/2016 - 11/2015
2	AntigensIBA 01/2016 - 06/2011
2	MethyltransferasesIBA 01/2016 - 10/2012
2	nasIBA 01/2016 - 05/2012
1	Ketoprofen (Orudis)FDA LinkGeneric 03/2024
1	CaspasesIBA 10/2022
1	bisantreneIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 03/2020
1	Naltrexone (ReVia)FDA LinkGeneric 03/2020
1	CytokinesIBA 03/2020
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2018
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2018
1	niraparibIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	4-nitrophenethyl bromide (NPB)IBA 01/2018
1	Transaminases (Aminotransferases)IBA 06/2017
1	Ketoconazole (Nizoral)FDA LinkGeneric 01/2017
1	Ethacrynic Acid (Etacrynic Acid)FDA Link 01/2017
1	Chlorambucil (Leukeran)FDA Link 01/2017
1	Sirolimus (Rapamycin)FDA Link 01/2017
1	Everolimus FDA Link 01/2017
1	Bortezomib (Velcade)FDA Link 11/2016
1	Complement System Proteins (Complement)IBA 10/2016
1	Messenger RNA (mRNA)IBA 09/2016
1	multidrug resistance-associated protein 1IBA 09/2016
1	Azacitidine (5 Azacytidine)FDA Link 01/2016
1	Annexin A5IBA 01/2016
1	Cladribine FDA LinkGeneric 01/2016
1	Sorafenib (BAY 43-9006)FDA Link 11/2014
1	fms-Like Tyrosine Kinase 3IBA 11/2014
1	Hydroxamic Acids (Hydroxamic Acid)IBA 10/2012
1	Histones (Histone)IBA 10/2012
1	Tacrolimus (Prograf)FDA LinkGeneric 06/2011
1	thymoglobulin FDA Link 06/2011
1	Tyrosine Kinase InhibitorsIBA 06/2011
1	A-Form DNA (A-DNA)IBA 03/2010
1	PhosphoproteinsIBA 10/2005
1	RNA Precursors (Precursor, mRNA)IBA 07/2005
1	Ribosomal DNA (rDNA)IBA 07/2004
1	transcription factor UBFIBA 07/2004

Therapy/Procedure

11	Hematopoietic Stem Cell Transplantation 02/2024 - 11/2008
6	Stem Cell Transplantation 01/2018 - 06/2011
5	Drug Therapy (Chemotherapy) 01/2022 - 05/2012
3	Therapeutics 01/2018 - 07/2010
1	Aftercare (After-Treatment) 10/2016